A series of new amphiphilic pyrrolidines containing dodecyl and oleyl apolar side chains were prepared and evaluated for their ability to inhibit the growth of pancreatic ductal adenocarcinoma cells in vitro. The new compounds are shown to exhibit anticancer activity at concentrations in the M range.
Introduction
In recent years, several compounds with amphiphilic structure have been proposed as a new type of potential anticancer agents due to the lipophilic nature of their lipid chains. Series of such compounds isolated from natural sources have indeed shown promising anticancer activities. For instance, Ircinamine B, isolated from marine sponge Dactylia, 1 and Melophlins Q 2 isolated from Palauan marine sponge are active against mouse leukemia cell lines in the M range. Alkylglycerols 3 from shark liver also show anticancer activity in vivo in the M range with no toxicity on human umbilical vein endothelial cells, the best compounds bearing unsaturated 16 and 18 carbon alkyl chains. Motuporamine C from a marine Sponge, 4 interferes with the migration of human breast carcinoma and glioma cells in culture with low toxicity in vitro. Sphingosine 4-sulfate 5 from the sponge Spirastrella abata shows cytotoxic effects on several human tumor cell lines. The glycosyl ceramide, Turbostatin 1,2,3,4, 6 from Asian marine mollusk Turbo stenogyrus, is active against leukemia cells in the low M range.
Notably, synthetic amphiphilic compounds have also shown interesting anticancer properties. As shown by Gajate and Mollinedo, 7-9 edelfosine (Figure 1 ), a lipid analogue of lysophosphatidyl-choline induces apoptosis in several tumor cell lines through its lipid ether moiety. Once edelfosine is inside the cell, it induces selective apoptosis in cancer cells through the activation of the Fas death receptor located on the surface of cells without the participation of the corresponding Fas ligand. 10
Figure 1
Other compounds such as Jaspines, having also amphiphilic character by combining a polar head (amino and hydroxy moieties) with aliphatic long chains, have shown good anticancer activities as well. Among the different diastereoisomeric Jaspines evaluated against human alveolar cell lines, Jaspine B (Figure 1 ) was the most active, showing cytotoxicity at nanomolar concentrations in in vitro assays. 11 Due to their amphiphilic nature, glycolipids and their analogues also show therapeutic potential. Numerous glycolipid derivatives have been proposed as antibacterial/antiviral agents, 12, 13 cell adhesion mediators, 14 and oral drug carriers. 15 In the past few years, glycolipids have also been proposed as new potential anticancer agents due to the lipophilic nature of their aglycones. A variety of synthetic glycolipids have been prepared and their anticancer properties evaluated. Thus, oleyl N-acetyl-α-and β-D-glucosaminides and their thioglycosyl analogues 1a and 1b ( Figure 2 ) exhibited antimitotic activity on rat glioma (C6) and human lung carcinoma (A549) cell cultures in the M range. 16, 17 Triazologlycolipids 2 showed cytotoxicity against a panel of cancer cell lines in the M range. 18 
Figure 2
Derivatization of iminosugars with aliphatic side chains has been extensively studied in order to improve their biological activity, lipophilicity and bioavailability. 19 For instance N-nonyl-1-
The promising results shown by compound 9 and derivatives, prompted us to explore further structural variations in order to improve their anticancer properties, in particular in pancreatic cancer cell lines. Thus, different series of compounds bearing amphiphilic character were prepared for structure-activity relationship studies by combining polyhydroxylated pyrrolidines with 2-fatty-alkyl moieties.
We report herein the synthesis of a series of this type of compounds starting from different sugars as source of chirality and the results of their evaluation in terms of toxicity in pancreatic cancer cell lines. The structural variations of the new compounds are shown in Figure 4 . The diversity at the new structures will allow us to examine the role of different configurations at the stereogenic centers, the type of linker (X), the distance between the side chain and the pyrrolidine skeleton and the role of different functionalities at the nitrogen atom on their anticancer activity. Thus, compound 19 was prepared from D-ribose as outlined in Scheme 1. Starting from the known D-ribose derivative 13, 28 reaction with ethyl triphenylphosphoranylidene acetate in dichloromethane at reflux afforded a mixture of alkenes 14 and 15 in 86% yield and a ratio E:Z 1:3.6. The stereoselectivity in the Wittig reaction was in accordance with that described in the literature for other ribo-lactols. 29 Mesylation of the free OH group in both alkenes followed by treatment with ammonia in ethanol led to pyrrolidine 16 as unique product (94% yield), through tandem conjugate addition-internal S N 2 displacement. Reductive amination with butanal, ester hydrolysis and amide coupling with oleyl amine in the presence of PyBOP and DIPEA afforded compound 18 in 30% yield (two last steps). Deprotection with TBAF led to pyrrolidine 19 in quantitative yield. Attempts to deprotect 19 with cold TFA aq. were unsuccessful. The preparation of other acetonide protected pyrrolidines with the same configuration have been reported. 30
Scheme 1. Synthesis of 19.
The effect of a triazole linker between the pyrrolidine skeleton and the side chain was also studied. These compounds were prepared by click chemistry upon reaction of the corresponding pyrrolidine azides with tetradec-1-yne. Differently configurated pyrrolidine azides were obtained from D-mannose, D-gulono-lactone and D-arabinose ( Figure 5 ).
The preparation of the azido-pyrrolidines is outlined in Scheme 2. Starting from known aldehyde 20, 31 reduction and tosylation gave derivative 21, which after displacement with sodium azide in DMF furnished azido derivative 22. Similarly, derivative 25 was obtained by azido displacement of the corresponding tosyl derivative 24 32 , obtained through oxidation, reduction and tosylation of known diol 23. 33 Derivative 28 was prepared from pyrrolidine ester 26, 34 by Cbz protection and reduction with LiAlH 4 followed by mesylation and azido displacement.
Scheme 2. Synthesis of azido-pyrrolidines.
The preparation of these azido derivatives requires benzyloxycarbonyl as N protecting group. The use of other carbamates as protecting groups for the preparation of the azido pyrrolidines gave unexpected results. Thus, tosylation of Boc-protected alcohol 29 did not lead to the corresponding tosyl derivative as expected. Instead, we mostly obtained cyclic carbamate 30 (Scheme 3) as confirmed by its spectral data. The 1 H-and 13 C NMR spectra of 30 did not show the typical signals for the tosyl and tert-butyl groups. However, a signal at 152.9 ppm was observed in the 13 C NMR spectra, corresponding to the carbonyl group of the carbamate.
Biological evaluation. The cytotoxic activity of the new amphiphilic derivatives has been evaluated on the pancreatic cancer cell lines MiaPaCa2 and PK9. The results are summarized in Table 1 . They all exhibited antiproliferative activity in the M range.
Although undoubtedly much research needs to be done in this area, the results shown here indicate that the amphiphilic compounds combining unsaturated alkyl chains and iminoalditols of defined configurations might be of interest for the definition of new anticancer agents to be used in the treatment of pancreatic cancer. (25) . A solution of NaIO 4 (3.0 g, 14.0 mmol) in H 2 O (40 mL) was added dropwise to a 0 ºC solution of diol 23 33 (2.36 g, 7.0 mmol) in THF (35 mL). After 45 min., THF was evaporated and the mixture extracted with CH 2 Cl 2 . The organic phases were washed with water, sat. aq. soln. of NaHCO 3 and brine, dried, filtered and concentrated. The aldehyde obtained was then dissolved in MeOH (40 mL), cooled to 0 ºC and NaBH 4 (260 mg, 6.8 mmol) was added. After 30 min., the mixture was diluted with CH 2 Cl 2 , and washed with water and brine. The organic phase was dried, filtered and concentrated. The crude alcohol so-obtained was then dissolved in dry pyridine (25 mL), TsCl (4.34 g, 22.8 mmol) was added and the mixture stirred at 20 o C for 12 h. Water was added dropwise under stirring and the mixture evaporated to dryness. The residue was dissolved in CH 2 Cl 2 and washed with water and brine. The organic phase was dried, filtered and concentrated. The tosylate ester 24 32 so-obtained was dissolved in DMF (30 mL) and NaN 3 (0.93 g, 14.2 mmol) was added. After heating to 50 ºC for 2.5 h, the solvent was evaporated and the residue diluted with CH 2 Cl 2 and washed with water and brine. The organic phase was dried, filtered, and concentrated. Purification by chromatography column (AcOEt:cyclohexane 1:1) 
Ethyl 7-O-tert-butyldiphenylsilyl-2,3,6-trideoxy-3,6-imino-4,5-O-isopropylidene-L-galactoheptanoate ((2S,3R,4S,5R)-2-tert-butyldiphenylsilyloxymethyl-5-ethoxycarbonylmethyl-3,4-O-isopropylidene-pyrrolidine-3,4-diol) (16

(2R,3R,4S)-N-Benzyloxycarbonyl-2-azidomethyl-3,4-O-isopropylidene-pyrrolidine-3,4-diol
(2R,3S,4R)-N-Benzyloxycarbonyl-2-azidoethyl-3,4-O-isopropylidene-pyrrolidine-3,4-diol (28)
. NaHCO 3 (155 mg, 1.84 mmol) and CbzCl (310 μL, 2.02 mmol) were added to a solution of 26 34 (421.7 mg, 1.84 mmol) in EtOH:H 2 O (1:1, 10 mL), and the mixture stirred at r.t for 3 h. Then, it was poured into a sat. aq. soln. of NaHCO 3 and extracted with AcOEt. The dried organic phase was evaporated and the obtained residue was purified by column chromatography over silica gel (AcOEt:cyclohexane, 1:3) affording the corresponding N-protected pyrrolidine (594.9 mg, 97%). Then, to a cooled (-10 ºC) suspension of LiAlH 4 (35 mg, 0.91 mmol) in anh. THF (3 mL), the protected pyrrolidine (274 mg, 0.756 mmol) in THF (5 mL) was added. After 10 min., sat. aq. soln. of Na 2 SO 4 (20 mL) was added dropwise and the mixture extracted with AcOEt. The dried organic phase was evaporated and the obtained residue was purified by column chromatography over silica gel (toluene:acetone, 5:1) to afford the corresponding hydroxyethyl pyrrolidine 27 (171 mg, 70%). To a solution of this compound (221 mg, 0.69 mmol) in anh. CH 2 Cl 2 (4 mL), anh. pyridine (3 mL) and MsCl (160 µL, 2.06 mmol) were added. After 1.5 h, the reaction was quenched with water (4 mL) and evaporated. The residue was diluted with CH 2 Cl 2, washed with water and brine, dried, filtered and concentrated. The crude product was then dissolved in anh. DMF (5 mL) and NaN 3 (135 mg, 2.06 mmol) was then added. The mixture was heated at 70 ºC for 3 h and then evaporated. The residue was dissolved in CH 2 Cl 2 , washed with water and brine, dried, filtered and concentrated. The resulting residue was purified by column chromatography (AcOEt:cyclohexane 1:4) to give pure 28 as an oil (144.8 mg, 61%, 2 steps).   28 (33) . Tetradec-1-yne (47 μL, 0.19 mmol), DIPEA (110 μL, 0.64 mmol) and CuI (11 mg, 0.06 mmol) were added to a solution of 28 (60 mg, 0.173 mmol) in toluene (1.5 mL). The mixture was stirred at r.t. for 24 h and then, a sat. aq. soln. of NaHCO 3 was added and extracted with AcOEt. The organic phases were dried, filtered and concentrated. Purification by chromatography column (AcOEt:cyclohexane 1:2) afforded the triazole derivative (76 mg, 81%). Deprotection of this compound (60 mg, 0.111 mmol) as indicated for the preparation of 31 Cell lines and culture conditions. MiaPaCa2 and PK9 pancreatic ductal adenocarcinoma cells were obtained from American Type Culture Collection (ATCC, Rockville, MD, U.S.A.). Cells were cultured in RPMI (Gibco, Paisley, United Kingdom) supplemented with 10% heat inactivated fetal calf serum (FCS; Amimed, BioConcept, Allschwil, Switzerland) and 1% penicillin/streptomycin at 37°C (BioConcept) in a humidified atmosphere of 95% air and 5% CO 2 .
(2R,3S,4R)-2-[(4''-Dodecyl)-1H-1,2,3-triazole-1-yl)ethyl)-pyrrolidine-3,4-diol hydrochloride
Colorimetric cell growth assays. 5 x 10 3 MiaPaCa2 or PK9 cells/well were plated in 96-well plates and allowed to adhere overnight. Thereafter, cells were incubated with or without compounds in a final volume of 200 μL medium for 72h. Subsequently, cell viability was measured with CellTiter96 Aqueous1 (Promega) according to the manufacturer's instructions. Means of triplicate wells were analyzed. IC 50 s were estimated using GraphPad Sofware (GraphPad, La Jolla, CA, USA).
